Plastic Surgery Archives

Evera Medical, a Foster City, CA manufacturer of the facial saline-adjustable implant FulFil, is reporting that more than 670 of the devices have been implanted in the last two years with “no serious adverse events.” The company markets its implants under two names, with FulFil™ being an international product, which was issued the European CE Mark in April for “augmentation of facial soft tissue, including lip augmentation,” and in the US the device is called VeraFil™, and it was cleared by the FDA for “augmentation and reconstruction in and around the orbit of the eye,” according to Evera Medical.
We have not seen this device before, so here’s a quick look at the company’s technology:

Read More

If you ever find yourself in the position of needing facial reconstructive surgery, you don’t want some generic “off the rack” mandible, do ya? Naaaa, you want some some artificial bones designed specifically for you to highlight your unique features.

Read More

Research is showing that women who have had breast implant surgery are more likely to attempt suicide later in life From the Washington Times:

“Dr. Lipworth [an epidemiologist at Vanderbilt University Medical Center] analyzed the medical histories and death certificate data on 3,527 women who had cosmetic breast implant surgery between 1965 and 1993, following them for almost two decades after their surgeries. She found the suicide rate was triple that of women without implants. The risk was greatest – seven times higher – for women who got implants after turning 45.”

Read More

There’s no doubt that breast implants serve a legitimate purpose, such as in cases of reconstruction. And yet, we’ve noticed the attention paid to breast augmentation technology far outstrips this limited role. You might say the desire for larger breasts in general has been occupying an ample portion of our male and female population’s interest for the past century or so.

Sifting through all these huge tracts of research may feel overwhelming — but don’t let your spirits sag. Our Breastgadget column keeps you up to date on important events in the breast industry.

Read More

Intercytex Group plc, a Cambridge, UK company, is reporting positive results from a recently completed Phase I trial of its allogeneic skin graft replacement, called ICX-SKN. For the common peasant, allogeneic means from an unrelated donor.

In the trial (which is published today in the July issue of Regenerative Medicine, available now for online viewing at www.futuremedicine.com), a full-thickness skin sample was excised from the upper arm of six volunteers and replaced with Intercytex’ skin graft replacement product, ICX-SKN. After 28 days both visual and histological analysis showed that in all volunteers the ICX-SKN grafts were rapidly vascularised and overgrown with the hosts’ own cells, resulting in a fully integrated skin graft that had closed and healed the wound site.

Read More

Canadian researchers are afraid the FDA’s stringent rules about MRI screening of silicone implants will negatively affect breast size. That is why they have devoted themselves to finding a cheap, easy blood test to detect leaky implants.

Read More